Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization

Chimeric antigen receptor (CAR) T cell therapies have achieved promising outcomes in several cancers; however, more challenging oncology indications may necessitate advanced antigen receptor designs and functions. Here we describe a bipartite receptor system composed of separate antigen-targeting an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Leung, Wai-Hang, Gay, Joel, Martin, Unja, Garrett, Tracy E., Horton, Holly M., Certo, Michael T., Blazar, Bruce R., Morgan, Richard A., Gregory, Philip D., Jarjour, Jordan, Astrakhan, Alexander
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629089/
https://ncbi.nlm.nih.gov/pubmed/31039141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124430
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados